Drug name - Nevanac

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8071648 NOVARTIS Topical nepafenac formulations
Dec, 2025

(2 years from now)

US8324281 NOVARTIS Topical nepafenac formulations
Dec, 2025

(2 years from now)

US7834059 NOVARTIS Topical nepafenac formulations
Jan, 2027

(4 years from now)

Drugs and Companies using NEPAFENAC ingredient

Market Authorisation Date: 19 August, 2005

Treatment: Method of treating ocular inflammation

Dosage: SUSPENSION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.1% SUSPENSION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.